Adia Med Sells 7% Stake in Adia Labs to CEO Larry Powalisz for $350,000

• Adia Med sold a 7% economic interest in Adia Labs to CEO Larry Powalisz for $350,000 in cash.
• Powalisz purchased seven membership units at $50,000 each, matching the unit price in the prior 30% sale to Live Oak Health.
• The company retains a majority economic interest, subject to Live Oak's option to acquire additional units.
• Purchased units are intended to carry 7% of Adia Labs' total voting power on member matters.
• Independent directors authorized the transaction with Live Oak's consent; use of proceeds requires independent director approval.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Adia Med Inc. published the original content used to generate this news brief via Newsfile (Ref. ID: 202610200800NEWSFILECNPR____20261020_319712_1) on October 20, 2026, and is solely responsible for the information contained therein.